Starpharma Holdings Limited
SPHRF
$0.084
$0.00020.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 790.80K | 813.10K | 570.40K | 569.20K | 2.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 790.80K | 813.10K | 570.40K | 569.20K | 2.62M |
| Cost of Revenue | 1.53M | 1.57M | 1.72M | 1.72M | 1.78M |
| Gross Profit | -735.70K | -756.50K | -1.15M | -1.15M | 834.50K |
| SG&A Expenses | 1.02M | 1.05M | 1.20M | 1.20M | 1.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.55M | 2.62M | 2.92M | 2.91M | 2.95M |
| Operating Income | -1.76M | -1.81M | -2.35M | -2.34M | -336.90K |
| Income Before Tax | -1.76M | -1.81M | -2.35M | -2.34M | -336.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.76M | -1.81M | -2.35M | -2.34M | -336.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.76M | -1.81M | -2.35M | -2.34M | -336.90K |
| EBIT | -1.76M | -1.81M | -2.35M | -2.34M | -336.90K |
| EBITDA | -1.71M | -1.76M | -2.30M | -2.30M | -282.20K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 416.20M | 416.20M | 412.00M | 412.00M | 410.86M |
| Average Diluted Shares Outstanding | 416.20M | 416.20M | 412.00M | 412.00M | 410.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |